Leveraging clinical data to change the way we treat Oncology patients.

OncoStats allows clinical information to be registered in a systematic and structured manner in a database, while at the same time being validated by an Oncologist. The data we gather is used to produce real-world evidence (RWE) that impacts the way oncology care is delivered.

Invest in Oncostats

What is OncoStats?

OncoStats allows clinical information to be registered in a systematic and structured manner in a database, while at the same time being validated by an Oncologist. The data we gather is used to produce real-world evidence (RWE) that impacts the way oncology care is delivered.

Clinical Data

Oncostats is a result of the combination of medical expertise and technology, with profound research and study. By having medical doctors and a software development team working together, we were able to create an efficient tool that understands the problem it is solving, and antecipates what the user needs.

Real World Evidence

OncoStats doesn’t need information on 10,000 patients to start delivering value. Give us 1 patient and we can already personalize decisions about their treatment. Give us just 100 patients with a rare disease and we can start changing the way every other patient with that disease gets treated.

Decision Support

We integrate the information that is collected with OncoStats with the most current international cancer guidelines and deliver instant feedback about diagnostics and treatment that aids clinical decision-making.

Sparked your curiosity?

If you’re looking to invest or simply to know more about Oncostats, we should definitely talk.

Who's it for?

Oncostats is a result of the combination of medical expertise and technology, with profound research and study. By having medical doctors and a software development team working together, we were able to create an efficient tool that understands the problem it is solving, and antecipates what the user needs.

Hospital Administrators

OncoStats improves exams efficiency, which results in lower costs overall. It also provides performance indicators which allow institutions to be recognized as an “Excellence/Reference” center, which ultimaltely leads to more patient referrals and attract more deals with Pharmaceuticals for clinical trials and RWE studies.

Doctors

Save time and energy when producing patient reports, improved quality of clinical information and reduced likelihood of errors by decision support on patient staging and on choosing the most appropriate therapy according to each patient’s characteristics.

Patients

Better care received, with a tool that they can take home during treatments to report adverse effects, receive support and keep in touch with their doctors.

Our team

OncoStats allows clinical information to be registered in a systematic and structured manner in a database, while at the same time being validated by an Oncologist. The data we gather is used to produce real-world evidence (RWE) that impacts the way oncology care is delivered.

Miguel Borges

ceo & founder

Roberto Machado

cto

Paulo Carvalho

cbdo

António Murta

Strategic Advisor

António has a degree in Systems Engineering from Minho University, MBA from the ISEE (University of Porto), AMP from INSEAD. Has also done post-graduate studies at ISEE and MIT.

Nuno Sousa

Strategic advisor

Nuno Sousa (MD, PhD) is a Full Professor at the School of Health Science, University of Minho. He is the Director of the Medical Degree at University of Minho. He serves at several medical education and medical assessment advisory boards.

Invest in this stellar team

If you’re looking to invest or simply to know more about Oncostats, we should definitely talk.